Allogene Therapeutics Inc Annual Shareholders Meeting Transcript
Good day, and welcome to the Allogene Therapeutics, Inc. 2020 Annual Meeting of Shareholders.
It is now my pleasure to turn today's meeting over to Dr. David Chang, Chief Executive Officer of Allogene Therapeutics. Dr. Chang, the floor is yours.
Good morning. This is David Chang, and I'm the Chief Executive Officer and the director of Allogene Therapeutics. I'm very happy to welcome you to the Allogene 2020 Annual Meeting of Stockholders. As you know, we are hosting today's meeting through a virtual online platform for health and safety reasons due to the COVID-19 pandemic. With that in mind, I want to thank you for taking the time to join us and hope you all safe and well.
In order to conduct an orderly meeting, we ask that you follow the rules of conduct, which are available on the meeting materials online. While the meeting is virtual only, stockholders of record will have the opportunity to submit questions or comments through the text box located on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
